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Summary: Background: Major amputations in patients with peripheral arterial disease (PAD) carry a high risk for
complications, including revision of the amputation, sometimes to a higher level. Determining a safe level for amputation
with good wound healing potential depends largely on vascular measurements. This study evaluated potential predictive
factors for revision of major lower extremity amputations in patients with PAD. Patients and methods: A retrospective chart
review of all major lower extremity amputations at our institution was conducted. Amputations due to trauma or tumor and
below-ankle amputations were excluded. Patient demographics, level/type of amputation, level/time of revision, comorbidi-
ties and risk factors were extracted. Results: 180 patients with PAD, mean age 66.48 (range: 31–93) years, 125 (69.4%) male
were included. Most (154/180, 86.6%) underwent below-knee amputation. 71 (39.4%) patients had coronary arterial disease,
104 (57.8%) had diabetes. More than half of patients, (93/138; 51.7%) had undergone previous balloon angioplasty. 44 (30%)
patients required revision surgery: 42/180 (23.3%) were revised at the same level, and in 12/180 (6.7%) a more proximal
amputation was necessary. PAD stage was not associated with the level of reamputation (p = 0.4369). Significantly more
patients who had previous balloon angioplasty required revision surgery (66.7% versus 45.2%, p = 0.009). 67 (37.2%) patients
underwent preoperative TcPO2 measurement: 40/67 (59.7%) had TcPO2  40 mmHg; 4/67 (6%) had TcPO2 < 10 mmHG. Three
patients with TcPO2  40 mmHg, one with 30 mmHg  TcPO2  40 mmHg and one with 10 mmHg  TcPO2  20 mmHg
required re-amputation to a more proximal level. Conclusions: TcPO2 measurements are useful for determining level of lower
limb amputation and predicting wound healing problems when an amputation level with TcPO2 < 40 mmHg is chosen.
In transtibial amputations, TcPO2  40 mmHg does not safely predict wound healing.
Keywords: Amputation, revision, level of amputation, peripheral arterial disease, TcPO2, diabetes mellitus
Introduction
In patients with advanced peripheral arterial disease
(PAD), amputation is often the last option for treatment
of uncontrollable pain or infection. Major amputations in
vascular compromised patients carry a high risk for compli-
cations, including revision of the amputation, sometimes to
a higher level. Across 12 studies, the mean revision rate
of 3,454 lower limb amputations was 16.3% (range:
13.4% to 56%) [1–12], with a mean rate of below-knee con-
version to a higher level of amputation of 12.9% (range: 0%
to 24%).
The healing potential of the amputation wound is
severely limited in patients with PAD, due to the reduced
perfusion of the area. The healing potential of the wound
is better when a more proximal surgery is performed, as
proximal perfusion is more likely to be sufficient in
these patients or can be improved through percutaneous
transluminal angioplasty (PTA) or open vascular surgery
[13]. Patients with PAD also usually have numerous comor-
bidities and risk factors [14], which can influence strategy
and level of amputation. If a vascular patient requires
amputation surgery due to ischemia of the limb, coronary
arterial disease (CAD) should be considered in addition
to PAD, and cardiac function should be evaluated [1, 2,
15]. The presence of CAD in addition to PAD is a primary
consideration when determining a safe level for performing
an amputation with a good healing potential and to avoid
major revision surgery [16, 17].
On the other hand, preservation of a major joint leads to
a higher probability of ambulation and less energy expendi-
ture [3, 18–21]. Since most vascular patients have severe
cardiac and pulmonary limitations as well, a below-knee
amputation provides a better likelihood for the patient to
resume ambulation.
2019 Hogrefe Vasa (2019), 1–6
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Given the above considerations, it is understandable why
a below-knee amputation would be preferred, if there is a
reasonable chance of success. Determining the level of
amputation for a patient depends largely on clinical vascular
measurements, through both non-invasive and invasive
techniques. Simple clinical investigations such as determin-
ing capillary refill or taking the pulses of thedorsal pedal and
posterior tibial artery may give a first impression of wound
healing potential. With structured training, duplex ultra-
sound is a low cost, reproducible, effective diagnostic tool
for detection of PAD [22]. If a diagnosis of PAD has been
made, revascularization strategies can be determined based
on the location andmorphology of the pathology. Ankle bra-
chial index (ABI) and transcutaneous oxygen pressure
(TcPO2) are measurements that can predict wound healing
potential [23, 24]. In a study by Poredos et al [24], TcPO2
levels > 40 mmHg predicted primary wound healing in
100%ofpatients,whileTcPO2 levels 10mmHgpredicted
0%primary wound healing. For intermediate TcPO2 levels,
primary healing rates ranged from 54%for 10–20mmHg, to
70% for 20–30mmHg, and 88% for 30–40mmHg.
The purpose of this study was to determine predictive
factors for revision of major lower extremity amputations
in patients with PAD and to investigate the effect of
preoperative TcPO2 levels on amputation level and the
need for revision.
Patients and methods
Study design
We conducted a retrospective chart review of prospectively
collected data of all major lower extremity amputations
performed at our institution between 2002 and 2016. Our
institution specializes in the treatment of patients with
diabetes and patients with PAD, poor vascular status or
ischemia. The search keyword for the in-house database
was “amputation”. Exclusion criteria were amputations
due to trauma or tumor within 20 cm of the amputation
level, primary amputations performed at another institu-
tion, and minor amputations (i.e., at or below the level of
the ankle) [25], which were all manually subtracted from
the primary search result. This study was reviewed and
approved by the local research ethics committee, and
informed consent was obtained according to the commit-
tee’s regulations.
Patient demographics and clinical data were derived
from the institutional electronic medical records. All data
were collected prospectively. In all cases, amputation level
was determined by a senior orthopedic surgeon, based on
angiologic evaluation, the presence of palpable pedal
pulses, TcPO2 values if palpable pedal pulses were absent,
sufficient mechanically resilient skin on the lower limb, and
the exclusion of alternative treatment options. All amputa-
tions were performed by or under the direct supervision of
an attending orthopedic surgeon. For TcPO2 measure-
ment, the room-temperature probe was applied at the
planned site of amputation, 12 to 15 cm below the knee joint
line for below-knee amputations, while the patient was
lying flat. Information collected included patient demo-
graphic data, level and type of amputation, whether the
revision was performed at the same level or a more
proximal level, time from amputation to first revision,
and presence of polyneuropathy or diabetic nephropathy.
For diabetes mellitus, the date of diagnosis, type (1 or 2),
duration, and treatment (none, insulin, oral antidiabetic
medications) were determined from the medical records.
Peripheral arterial disease was graded using Fontaine
stages I to IV [26], and it was noted whether ipsilateral
PTA or peripheral bypasses were performed prior to ampu-
tation. Risk factors including smoking and alcohol use [27]
were extracted.
Statistical analysis
Data were analyzed using IBM SPSS Statistics version 20.0
(IBM Corp, Armonk, New York). Differences in categorical
variables between patients who underwent revision and
those without revision were analyzed using chi-square
tests. Differences in continuous variables were analyzed
using logistic regression. Differences in PAD stage between
patients who underwent revisions at the same level or level
above were analyzed using Fisher’s exact test. The level of
statistical significance was set at α = 0.05.
Results
Patient demographics and comorbidities
A total of 182 patients with PAD who underwent major
lower extremity amputation between 2002 and 2016 were
identified. Two patients were excluded due to missing
follow-up data. Of the remaining 180 patients, 125 (69%)
were males, with a mean age at first amputation of
65.7 years (range: 32 to 90) (Table I). The 55 females had
a mean age of 68.6 years (range: 31 to 93). Mean follow-
up was 814 (range: 3 to 4,229) days. 34 patients (18.9%)
died during the study period, at a mean of 766 (range:
3 to 3,512) days after the first amputation. The cause of
death was related to the underlying severe infection in four
patients; the cause of death was not listed in the charts for
the remaining 30 patients.
Almost one-half of patients (83/180, 46.1%) had PAD at
Fontaine stage IV (Table I). Patients in the early stages of
PAD (I and IIa) who required amputation had severe soft
tissue infection or osteomyelitis (n = 20), a combination
of infection and ischemia (n = 5), or new onset of gangrene
(n = 4).
A diagnosis of CADwas recorded for 71 patients (39.4%),
and 93 patients (51.7%) had undergone a previous balloon
angioplasty. A diagnosis of diabetes mellitus was recorded
for 104 (57.8%) patients: 22/104 (21.2%) had type I dia-
betes and 82/104 (78.9%) had type 2 diabetes. Most of
the diabetic patients (70.1%) were taking insulin injections.
Vasa (2019), 1–6 2019 Hogrefe
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The most common reasons for amputation were infec-
tion (27.8%), gangrene (23.9%), acute ischemia (18.3%),
and combined gangrene and infection (15.0%) Most
patients (154/180, 86.6%) underwent below-knee amputa-
tion as the index operation (Table I). 25 patients underwent
bilateral amputations.
Patients with PAD who required revision of the amputa-
tion were similar to patients with PAD who did not undergo
revision for gender, age, level of amputation, reason for
amputation, PAD stage, CAD, diabetes, smoking status
and alcohol consumption (Table I). Although more patients
who required amputation due to acute ischemia subse-
quently underwent revision (27.8% versus 14.3%) and
fewer patients who required amputation due to infection
subsequently underwent revision (20.4% versus 30.9%),
these differences were not statistically significant
(p = 0.201). Significantly more patients with PAD who
required revision of the amputation had undergone a
Table I. Demographics of patients who underwent major lower extremity amputation (n = 180) and amputation patients who required revision
surgery (n = 54).
All amputation
patients (n = 180)
Revision
patients (n = 54)
No revision
(n = 126)
P-value
Gender: male 125 (69.4%) 41 (75.9%) 84 (66.7%) 0.2891
Age, years; mean (range) 66.48 (31–93) 65.58 (35–84) 68.93 (31–92) 0.3882
Bilateral amputation 25 (13.9%) 11 (20.4%) 14 (11.1%) 0.106^
Level of amputation or revision: 0.356^
Below knee (i.e., transtibial) 154 (85.6%) 44 (81.5%) 110 (87.3%)
Above knee (i.e., transfemoral) 26 (14.4%) 10 (18.5%) 16 (12.7%)
Reason for amputation: 0.201^
Infection 50 (27.8%) 11 (20.4%) 39 (30.9%)
Gangrene 43 (23.9%) 12 (22.2%) 31 (24.6%)
Acute ischemia 33 (18.3%) 15 (27.8%) 18 (14.3%)
Gangrene and infection 27 (15%) 9 (16.7%) 18 (14.3%)
Osteomyelitis 10 (5.6%) 2 (3.7%) 8 (6.3%)
Ischemia and infection 4 (2.2%) 2 (3.7%) 2 (1.6%)
Recurrent foot ulcer 4 (2.2%) 1 (1.8%) 3 (2.4%)
Other1 9 (5%) 2 (3.7%) 7 (5.6%)
PAD stage2 0.231^
No stage assigned 44 (24.4%) 11 (20.4%) 33 (26.2%)
Stage I 17 (9.4%) 4 (7.4%) 13 (10.3%)
Stage IIa 12 (6.7%) 0 12 (9.5%)
Stage IIb 17 (9.5%) 5 (9.3%) 12 (9.5%)
Stage III 7 (3.9%) 3 (5.6%) 4 (3.2%)
Stage IV 83 (46.1%) 31 (57.4%) 52 (41.3%)
Coronary arterial disease 71 (39.4%) 25 (46.3%) 46 (36.5%) 0.246^
Diabetes mellitus 104 (57.8%) 36 (66.7%) 68 (54.0%) 0.139^
Previous balloon angioplasty 93 (51.7%) 36 (66.7%) 57 (45.2%) 0.009^
TcPO2 (n = 67) (n = 24) (n = 43) 0.382
 40 mmHg 40/67 (59.7%) 16/24 (66.7%) 24/43 (55.8%)
 30 to < 40 mmHg 16/67 (23.9%) 5/24 (20.8%) 11/43 (25.6%)
 20 to < 30 mmHg 3/67 (4.5%) 1/24 (4.2%) 2/43 (4.7%)
 10 to < 20 mmHg 4/67 (6%) 2/24 (8.4%) 2/43 (4.7%)
< 10 mmHg 4/67 (6%) 0 4/43 (9.3%)
Smoking (n = 158) (n = 50) (n = 108) 0.465^
Never 61/158 (38.6%) 20/50 (40.0%) 41/108 (38.0%)
Yes – currently 46/158 (25.3%) 17/50 (34.0%) 29/108 (26.9%)
Former Smoker (date of discontinuation not available) 51/158 (32.3%) 13/50 (26.0%) 38/108 (35.2%)
Alcohol consumption: yes 83/170 (48.8%) 27/51 (52.9%) 56/119 (47.1%) 0.486^
< 1 glass of beer or wine/day 51/170 (30.0%) 14/51 (25.9%) 37/119 (31.1%)
1 glass of beer or wine/day 13/170 (7.6%) 6/51 (11.8%) 7/119 (5.9%)
> 1 glass of beer or wine/day 19/170 (11.2%) 7/51 (13.7%) 12/119 (10.1%)
1Other reasons include: tumor at the level of the foot (n = 3), Charcot neuroarthropathy (n = 2), delayed nonunion after ankle fusion (n = 2), complex regional
pain syndrome (n = 1); insufficient bone stock for a fifth revision of total knee arthroplasty (n = 1).
2PAD: peripheral arterial occlusive disease. Stages according to Fontaine et al (1954) (26); in 44 patients, no PAD stage was assigned; ^Chi-square analysis;
+T-test;  Logistic regression.
2019 Hogrefe Vasa (2019), 1–6
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previous PTA compared to patients who did not require
revision (66.7% versus 45.2%, p = 0.009).
Revision surgery
54 (30%) patients required revision surgery; 42/54 (77.7%)
underwent revision at the same level, and 12/54 (22.2%)
required revision to a more proximal level (11 to trans-
femoral, 1 to through the knee). Themean time from ampu-
tation to first revision was 92.7 (range: 5 to 642) days. 10 of
54 patients (18.5%) underwent more than one revision sur-
gery. Three patients underwent two revisions: one patient
was converted from transtibial to transfemoral level after
145 days due to skin necrosis and ischemia; two patients
were revised at the same level. Seven patients underwent
three or more revisions: four with soft tissue infection,
two with delayed wound healing, and one with a planned
second and third investigation after undergoing amputa-
tion due to necrotizing fasciitis; none of these patients were
converted to a more proximal level.
The PAD stage was known for 43 of 54 (79.6%) patients
who required revision surgery (Table II). Seven of
11 (63.6%) patients with stage I, II, or III PAD and 24 of
31 (77.4%) patients with stage IV PAD underwent revision
at the same level (p = 0.4369). One patient who underwent
two revisions, first at the same level and subsequently at a
moreproximal level,wasexcludedfromthisanalysis.TcPO2
levels 67 (37.2%) of 180 patients in this retrospective study
underwent preoperative TcPO2 measurement. Of these,
40 patients (59.7%) had a preoperative TcPO2 40mmHg
Table I), which is considered the limit above which wound
healing canbe expected. Interestingly, the four patientswith
TcPO2 < 10mmHg did not require revision.
In the 67 patients with preoperative TcPO2 measure-
ments available, 64 (95.5%) underwent below-knee ampu-
tation and 3 (4.5%) underwent above-knee amputation
(Table III). Twenty-three (35.9%) below-knee amputations
required revision, and 1 (33.3%) above-knee amputation
required revision.
The overall revision rate was 35.8% for patients with a
preoperative TcPO2 measurement compared to 26.5% for
patients who had no preoperative TcPO2 measurements
(p = 0.239, Fisher’s exact test). A single revision was per-
formed in 29.9% of patients with preoperative TcPO2mea-
surements available and 20.4% of patients without TcPO2
measurements (p = 0.239). Wound revisions were per-
formed in 28.4% of patients with preoperative TcPO2mea-
surements available and in 16.8% of patients without
preoperative TcPO2 measurements (p = 0.088).
TcPO2measurements were available for 24 patients who
required revision surgery. Of these, 16 (66.7%) patients had
TcPO2 levels  40 mmHg, 5 (20.8%) patients had TcPO2
levels between 30 and 40 mmHg, 1 (4.2%) patient had
TcPO2 levels between 20 and 30 mmHg, and 2 (8.3%)
patients had TcPO2 levels between 10 and 20 mmHg. 19
(79.2%) of 24 patients underwent revision at the same
level, whereas 5 (20.8%) were revised to the level above
(Table III).
Discussion
Determining the level of amputation in the lower limb is a
challenge to the treating surgeon. Several elements, such as
comorbidities, capability of assimilating additional energy
expenditure, and simplicity of seating position, must be
considered. In patients with PAD, poor vascular status or
ischemia, wound healing potential has a crucial influence
on the choice of amputation level. In our study population
of 180 patients with PAD who underwent lower limb
amputation, 30% required revision surgery, with 6.7%
subsequently converted to a more proximal level. Many
of these patients also had insulin-dependent diabetes
mellitus or CAD.
While many studies have evaluated risk factors for
primary lower limb amputation in patients with PAD or
critical limb ischemia, the literature on risk factors for revi-
sion surgery following primary lower limb amputation is
sparse. Wu et al. [28] reported that end-stage renal failure
and preoperative non-ambulatory status were independent
risk factors for subsequent above-knee amputation in
210 Asian patients with PAD who underwent below-knee
amputation. In our study, the only patient factor associated
with revision surgery was having undergone a previous
PTA (p = 0.009]. Balloon angioplasty is often considered
a surrogate indicator of more severe peripheral vascular
disease. As such, PTA is typically only performed in clini-
cally critical patients where the surgeon has concerns about
the extent of vascular dysfunction, to aid in decision
making regarding the level of amputation, and to poten-
tially improve wound healing following amputation as part
of the limb salvage procedure.
The overall revision rate of 30% in our study population
is lower than the 56% rate observed by Inderbitzi et al in 66
consecutive patients with PAD who underwent bilateral
lower limb amputation [1]. While our rate was higher than
the mean revision rate of 16.3% observed in 3,454 lower
limb amputations across 12 studies [1–12], some of these
studies were not limited to patients with PAD and instead
consisted of patient populations with no or varied comor-
bidities [7, 9–11]. In our study, 6.7% of patients who
underwent amputation required conversion of their ampu-
tation to a more proximal level, which is lower than the
mean rate of below-knee conversion to a higher level of
amputation of 12.9% (range: 0% to 24%) observed in the
other studies [1–12].
Poredos et al. [24] reported that TcPO2 levels
> 40 mmHg predicted primary wound healing in 100%
Table II. PAD stage and level of revision for patients who underwent
reoperation (revision) of lower limb amputation.
PAD stage Level of revision*
Same level (n = 31)
Stage I, II, or III (n = 11) 7 (63.6%)
Stage IV (n = 31) 24 (77.4%)
* One patient underwent 2 revisions, one at the same level and subse-
quently one at a more proximal level, and was excluded from the table.
Vasa (2019), 1–6 2019 Hogrefe
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of patients in a series of 56 patients who underwent below-
knee amputation for ischaemic limb gangrene, whereas
TcPO2 levels  10 mmHG predicted 0% primary wound
healing. In our study, three patients with TcPO2
levels > 40 mmHg before the index amputation required
reamputation at a more proximal level. In each of those
cases, the indication for reamputation was progressive skin
necrosis and declining arterial blood supply, as judged by
the treating angiologist. Only two patients with a TcPO2-
level < 40 mmHg required revision at a higher level in
our study. These findings would suggest that determination
of TcPO2 levels at the proximal third of the tibia does not
safely predict wound healing potential in patients with
PAD.
In partial foot amputations, TcPO2 levels were found to
be predictive of wound healing potential [24, 29], which
indicates its value in decision-making around amputation
level when treating patients with diabetes and/or patients
with PAD, poor vascular status or ischemia. While the
predictive value of TcPO2 levels in our study was not
demonstrated, perhaps in part due to the limited number
of patients for whom this information was available, we
believe that the preoperative measurement of the TcPO2
is still a useful tool to provide objective values for discus-
sion of amputation level with the patient.
Many patients with PAD and/or diabetes have signifi-
cant comorbidities, particularly coronary heart disease,
which limits the physical effort they can undertake follow-
ing lower limb amputation. A below-knee amputation was
undertaken in some patients with low preoperative TcPO2
values to preserve lower limb length and minimize the
physical effort required for ambulation. In most of these
cases, only minor revisions for wound healing problems
were observed. Only one patient required revision at a
higher level.
Limitations
Limitations of this study include the retrospective study
design, which limited the patient demographic data avail-
able for review and may have introduced unintentional
bias. Another limitation is the availability of preoperative
TcPO2 levels for only a subset of patients in our study
who underwent lower limb amputation. TcPO2 is not
routinely performed in all patients who are scheduled for
amputation at our institution. The results of this and other
studies indicate that a prospective study of preoperative
TcPO2measurement of all patients undergoing lower limb
amputation is needed to further elucidate its predictive
value for reoperation following primary amputation.
Conclusions
In conclusion, PAD stage is not predictive of a need for revi-
sion surgery following lower limb amputation. TcPO2mea-
surements are a useful adjunct tool to determine the level
of lower limb amputation and to predict wound healing
problems in cases where an amputation level with TcPO2
values below 40 mmHg is chosen. However, in transtibial
amputations, values above 40mmHg do not safely predict
wound healing, and both the patient and the treating
surgeon should be prepared for reamputation at a more
proximal level.
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